Article references (16 references )


  1. Mottet N et al. Cancer of the penis: association Francaise d'Urologie Cancer Committee guidelines. Prog Urol. 2008; 18(10): 685-6. PubMed | Google Scholar

  2. Aynaud O, Ionesco M, Barrasso R. Penile intraepithelial neoplasia: Specific clinical features correlate with histologic and virologic findings. Cancer. 1994; 74(6): 1762-7. PubMed | Google Scholar

  3. Rigaud J et al. Recommendations Onco-Urology 2010: Malignancies of the penis. Prog Urol. 2010; 20 Suppl 4: S279-89. PubMed

  4. Horenblas S, van Tinteren H. Squamous cell carcinoma of the penis IV: prognostic factors of survival: analysis of tumor, nodes and metastasis classification system. J Urol. 1994; 151(5): 1239-43. PubMed | Google Scholar

  5. Minhas S et al. What surgical resection margins are required to achieve oncological control in men with primary penile cancer. BJU Int. 2005; 96(7): 1040-3. PubMed | Google Scholar

  6. Pizzocaro G et al. EAU penile cancer guidelines 2009. Eur Urol. 2010; 57(6): 1002-12. PubMed | Google Scholar

  7. Moses KA et al. Contemporary management of penile cancer: greater than 15 year MSKCC experience. Can J Urol. 2014; 21(2): 7201-6. PubMed | Google Scholar

  8. Leijte JA et al. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol. 2008; 54(1): 161-8. PubMed | Google Scholar

  9. Lont AP et al. Penis conserving treatment for T1 and T2 penile carcinoma: clinical implications of a local recurrence. J Urol. 2006; 176(2): 575-80. PubMed | Google Scholar

  10. Crook JM et al. American Brachytherapy Society-Groupe Europeen de Curietherapie-European Society of Therapeutic Radiation Oncology (ABS-GEC-ESTRO) consensus statement for penile brachytherapy. Brachytherapy. 2013; 12(3): 191-8. PubMed | Google Scholar

  11. Iborra F et al. [Management of lymph node regions in malignant penile tumors]. Prog Urol. 2005; 15(4 Suppl 2): 823-8. PubMed | Google Scholar

  12. Graafland NM et al. Prognostic factors for occult inguinal lymph node involvement in penile carcinoma and assessment of the high-risk EAU subgroup: a two-institution analysis of 342 clinically node-negative patients. Eur Urol. 2010; 58(5): 742-7. PubMed | Google Scholar

  13. Solsona E et al. EAU Guidelines on Penile Cancer. Eur Urol. 2004; 46(1): 1-8. PubMed | Google Scholar

  14. Theodorescu D et al. Outcomes of initial surveillance of invasive squamous cell carcinoma of the penis and negative nodes. J Urol. 1996; 155(5): 1626-31. PubMed | Google Scholar

  15. Bouchot O et al. Morbidity of inguinal lymphadenectomy for invasive penile carcinoma. Eur Urol. 2004; 45(6): 761-5. PubMed | Google Scholar

  16. Protzel C, Hakenberg OW. Chemotherapy in patients with penile carcinoma. Urol Int. 2009; 82(1): 1-7. PubMed | Google Scholar